whats going with promotion of Saizen, Serostim, Gonal-F and Ovidrel

Discussion in 'Serono' started by Anonymous, Nov 19, 2014 at 5:45 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Hello Guys,

    I am researching on various therapeutic areas in reference with the sales function and would like to know about above mentioned drugs and their promotion and how many reps currently associated with these products across nation...your help will be highly appreciated...looking forward to your genuine replies.
     

  2. Anonymous

    Anonymous Guest

    Piss off!!!!!! This is infertility. Just a bunch of old washed up hacks here.
     
  3. Anonymous

    Anonymous Guest

    Here you go.....

    Ovidrel no longer promoted
    Gonal f small sales force downsized multiple times no future
    Serostim small sales force downsized multiple times no future
    Saizen downsized sales force small also most through call center
    Rebif downsized sales force no future no pipeline

    That sums it up no future no pipeline
     
  4. Anonymous

    Anonymous Guest

    Infertility most stable
     
  5. Anonymous

    Anonymous Guest

    Most stable? That is so sad.
    Gonal-F's patent is up in June 2015. There are biosimilars about to enter the market. We have one product and are engaged in a price cutting war with the other 2 competitors. Oh yeah... and no pipeline to speak of. Hmmm.. didn't Serono just spend millions on a Millipore acquisition? Likely to spend more on fertility? In a word, no. Stable with a very uncertain future is more like it.
     
  6. Anonymous

    Anonymous Guest

    Anyone who thinks fertility is stable is clearly not stable themselves....... If you are working in the specialty and have a half a brain you would have figured this out a long time ago. Look at what is going on at merck.

    It's over folks!!!